↓ Skip to main content

Prospective evaluation of prognostic factors uPA/PAI-1 in node-negative breast cancer: Phase III NNBC3-Europe trial (AGO, GBG, EORTC-PBG) comparing 6 × FEC versus 3 × FEC/3 × Docetaxel

Overview of attention for article published in BMC Cancer, April 2011
Altmetric Badge

Citations

dimensions_citation
44 Dimensions

Readers on

mendeley
60 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Prospective evaluation of prognostic factors uPA/PAI-1 in node-negative breast cancer: Phase III NNBC3-Europe trial (AGO, GBG, EORTC-PBG) comparing 6 × FEC versus 3 × FEC/3 × Docetaxel
Published in
BMC Cancer, April 2011
DOI 10.1186/1471-2407-11-140
Pubmed ID
Authors

Eva J Kantelhardt, Martina Vetter, Marcus Schmidt, Corinne Veyret, Doris Augustin, Volker Hanf, Christoph Meisner, Daniela Paepke, Manfred Schmitt, Fred Sweep, Gunter von Minckwitz, Pierre-Marie Martin, Fritz Jaenicke, Christoph Thomssen, Nadia Harbeck

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 60 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 2%
Unknown 59 98%

Demographic breakdown

Readers by professional status Count As %
Researcher 14 23%
Student > Master 7 12%
Student > Bachelor 7 12%
Student > Ph. D. Student 5 8%
Professor 4 7%
Other 9 15%
Unknown 14 23%
Readers by discipline Count As %
Medicine and Dentistry 25 42%
Agricultural and Biological Sciences 7 12%
Biochemistry, Genetics and Molecular Biology 5 8%
Pharmacology, Toxicology and Pharmaceutical Science 4 7%
Psychology 2 3%
Other 3 5%
Unknown 14 23%